Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
47.94
Dollar change
-0.32
Percentage change
-0.66
%
Index- P/E- EPS (ttm)-0.15 Insider Own28.03% Shs Outstand66.70M Perf Week1.33%
Market Cap3.20B Forward P/E12.67 EPS next Y3.78 Insider Trans0.01% Shs Float48.11M Perf Month6.30%
Income-10.10M PEG- EPS next Q0.77 Inst Own80.35% Short Float5.08% Perf Quarter-36.45%
Sales2.99B P/S1.07 EPS this Y-36.32% Inst Trans0.57% Short Ratio2.43 Perf Half Y-32.66%
Book/sh75.05 P/B0.64 EPS next Y43.91% ROA-0.12% Short Interest2.44M Perf Year-45.19%
Cash/sh2.50 P/C19.16 EPS next 5Y7.20% ROE-0.20% 52W Range41.75 - 98.67 Perf YTD-34.95%
Dividend Est.- P/FCF45.20 EPS past 5Y- ROI-0.14% 52W High-51.41% Beta0.11
Dividend TTM- Quick Ratio0.88 Sales past 5Y72.88% Gross Margin42.84% 52W Low14.83% ATR (14)1.80
Dividend Ex-Date- Current Ratio1.57 EPS Y/Y TTM-101.18% Oper. Margin8.17% RSI (14)45.02 Volatility2.46% 3.21%
Employees7100 Debt/Eq0.52 Sales Y/Y TTM-8.34% Profit Margin-0.34% Recom2.88 Target Price56.57
Option/ShortYes / Yes LT Debt/Eq0.49 EPS Q/Q-77.04% Payout0.00% Rel Volume0.52 Prev Close48.26
Sales Surprise-6.81% EPS Surprise-42.60% Sales Q/Q-14.27% EarningsFeb 13 AMC Avg Volume1.01M Price47.94
SMA203.02% SMA50-13.79% SMA200-31.43% Trades Volume522,606 Change-0.66%
Date Action Analyst Rating Change Price Target Change
Mar-04-24Downgrade UBS Neutral → Sell $70 → $42
Feb-14-24Downgrade JP Morgan Neutral → Underweight $66 → $37
Dec-11-23Downgrade Citigroup Buy → Neutral $95 → $72
Dec-12-22Upgrade Citigroup Neutral → Buy $90 → $125
Dec-07-22Initiated RBC Capital Mkts Outperform $125
Oct-14-22Upgrade UBS Sell → Neutral $86
Sep-19-22Initiated Citigroup Neutral $90
Jul-20-22Initiated UBS Sell $86
Jun-17-22Resumed JP Morgan Neutral $80 → $110
Feb-22-22Upgrade Raymond James Outperform → Strong Buy $155 → $130
Mar-14-24 07:23AM
Mar-07-24 10:44AM
Mar-06-24 04:35PM
Feb-26-24 04:30PM
Feb-21-24 07:30AM
05:27AM Loading…
05:27AM
Feb-20-24 01:49PM
Feb-14-24 08:34PM
10:05AM
09:22AM
Feb-13-24 07:30PM
05:30PM
04:40PM
04:05PM
Feb-12-24 09:16AM
07:00AM Loading…
Jan-23-24 07:00AM
Dec-22-23 07:00AM
Dec-20-23 04:05PM
Dec-13-23 05:10AM
Nov-16-23 05:05PM
Nov-01-23 05:56PM
04:05PM
Oct-17-23 03:43PM
Oct-12-23 07:00AM
Sep-21-23 04:05PM
07:02AM
Aug-28-23 04:05PM
Aug-08-23 04:30PM
Jul-25-23 04:00PM
01:12PM
08:15AM Loading…
Jul-19-23 08:15AM
Jul-18-23 04:05PM
Jun-21-23 08:00PM
Jun-12-23 11:20AM
May-23-23 07:00AM
May-04-23 07:50AM
May-03-23 04:05PM
Apr-26-23 08:00PM
Apr-13-23 04:05PM
Mar-28-23 11:05AM
07:54AM
Mar-23-23 12:19PM
Mar-13-23 01:00PM
Mar-08-23 04:05PM
Mar-04-23 09:08AM
08:19AM
Mar-02-23 02:01PM
Feb-27-23 11:00AM
05:13AM
Feb-26-23 08:04AM
Feb-18-23 07:14AM
Feb-16-23 06:18PM
12:07PM
Feb-15-23 04:05PM
Feb-09-23 06:34AM
Jan-24-23 03:25PM
Jan-06-23 04:05PM
Jan-03-23 09:53AM
Dec-28-22 07:00AM
Dec-20-22 06:08PM
09:37AM
Dec-19-22 03:15PM
Dec-16-22 11:05AM
09:21AM
Dec-12-22 04:54PM
Dec-08-22 02:13PM
Nov-30-22 04:05PM
Nov-08-22 11:05AM
Nov-03-22 06:38PM
Nov-02-22 04:05PM
Oct-19-22 06:54AM
Oct-12-22 04:05PM
Oct-04-22 09:00AM
Sep-06-22 08:00AM
Sep-03-22 09:00AM
Sep-02-22 06:46AM
Sep-01-22 12:00PM
Aug-24-22 09:00AM
Aug-17-22 04:30PM
Aug-12-22 01:27PM
Aug-09-22 12:08PM
Aug-04-22 04:10PM
Jul-27-22 07:24AM
Jul-26-22 09:35AM
Jul-24-22 05:30AM
Jul-18-22 04:05PM
Jul-04-22 03:57PM
Jun-21-22 07:00PM
Jun-09-22 09:00AM
Jun-03-22 11:32AM
Jun-01-22 08:56AM
May-27-22 09:00AM
May-26-22 12:24PM
May-19-22 06:28AM
May-16-22 04:45PM
04:45PM
May-05-22 11:21AM
09:52AM
May-04-22 05:55PM
04:10PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Busky Joseph MChief Financial OfficerFeb 23 '24Buy46.352,15099,6632,150Feb 26 06:48 PM